Current Neuro-Oncology

Volume 3 Number 2
28 February 2001

Home > Publications > Current Neuro-Oncology > Volume 3, Year 2001 > Number 2, 28 February

Mariani L, Schroth G, Wielepp JP, Haldemann A, Seiler RW.
Intratumoral arteriovenous shunting in malignant gliomas.
Neurosurgery. 2001 Feb;48(2):353-7. doi: 10.1097/00006123-200102000-00022
. PMID: 11220379. Case report. ˍ

Simmons ML, Lamborn KR, Takahashi M, Chen P, Israel MA, Berger MS, Godfrey T, Nigro J, Prados M, Chang S, Barker FG 2nd, Aldape K.
Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients.
Cancer Res. 2001 Feb 1;61(3):1122-8
. PMID: 11221842. Observational study. ˍ

Yu JS, Wheeler CJ, Zeltzer PM, Ying H, Finger DN, Lee PK, Yong WH, Incardona F, Thompson RC, Riedinger MS, Zhang W, Prins RM, Black KL.
Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration.
Cancer Res. 2001 Feb 1;61(3):842-7∟. PMID: 11221866∟. Interventional study.

Fisher BJ, Scott C, Macdonald DR, Coughlin C, Curran WJ.
Phase I study of topotecan plus cranial radiation for glioblastoma multiforme: results of Radiation Therapy Oncology Group Trial 9507.
J Clin Oncol. 2001 Feb 15;19(4):1111-7
. doi: 10.1200/JCO.2001.19.4.1111. PMID: 11181676. Interventional study. ˍ

Geoerger B, Kerr K, Tang CB, Fung KM, Powell B, Sutton LN, Phillips PC, Janss AJ.
Antitumor activity of the rapamycin analog CCI-779 in human primitive neuroectodermal tumor/medulloblastoma models as single agent and in combination chemotherapy.
Cancer Res. 2001 Feb 15;61(4):1527-32
. PMID: 11245461. Laboratory investigation. ˍ